When our data on circulating MMP or TIMP levels in patients with IPF are considered in the context of data from experimental models of fibrosis, a clearer view emerges of the potential mechanism(s) by which altered MMP/TIMP expression contributes to lung fibrosis. This evidence concerns the gene TIMP1 and idiopathic pulmonary fibrosis.